相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2021)
Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease PPARα Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development
Julius L. Decano et al.
CIRCULATION (2021)
Modular gateway-ness connectivity and structural core organization in maritime network science
Mengqiao Xu et al.
NATURE COMMUNICATIONS (2020)
PCSK9Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis
Qianyun Guo et al.
FRONTIERS IN GENETICS (2020)
Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events randomized clinical trial
Alexander Kulik et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)
Network-based prediction of drug combinations
Feixiong Cheng et al.
NATURE COMMUNICATIONS (2019)
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis
Karla Solo et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis
MacIntosh Cornwell et al.
BMC BIOINFORMATICS (2018)
PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages
Zufeng Ding et al.
CARDIOVASCULAR RESEARCH (2018)
Role of smooth muscle cells in coronary artery bypass grafting failure
Kerry Wadey et al.
CARDIOVASCULAR RESEARCH (2018)
Inflammatory and Cholesterol Risk in the FOURIER Trial
Erin A. Bohula et al.
CIRCULATION (2018)
Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy
Aruna D. Pradhan et al.
CIRCULATION (2018)
PCSK9 From Basic Science Discoveries to Clinical Trials
Michael D. Shapiro et al.
CIRCULATION RESEARCH (2018)
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Alena Grebe et al.
CIRCULATION RESEARCH (2018)
Pleiotropic Anti-atherosclerotic Effects of PCSK9 Inhibitors From Molecular Biology to Clinical Translation
Angelos D. Karagiannis et al.
CURRENT ATHEROSCLEROSIS REPORTS (2018)
HPEPDOCK: a web server for blind peptide-protein docking based on a hierarchical algorithm
Pei Zhou et al.
NUCLEIC ACIDS RESEARCH (2018)
PCSK9 induces a pro-inflammatory response in macrophages
Chiara Ricci et al.
SCIENTIFIC REPORTS (2018)
Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study
Jing Gao et al.
BMJ OPEN (2018)
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Marc P. Bonaca et al.
CIRCULATION (2018)
Inflammation in Vein Graft Disease
Margreet R. de Vries et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia
Sophie J. Bernelot Moens et al.
EUROPEAN HEART JOURNAL (2017)
Interleukin-1 Beta as a Target for Atherosclerosis Therapy Biological Basis of CANTOS and Beyond
Peter Libby
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Heparan sulfate proteoglycans present PCSK9 to the LDL receptor
Camilla Gustafsen et al.
NATURE COMMUNICATIONS (2017)
Activation and inflammation of the venous endothelium in vein graft disease
Alexander O. Ward et al.
ATHEROSCLEROSIS (2017)
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway
Zhi-Han Tang et al.
ATHEROSCLEROSIS (2017)
PCSK9 regulates the chemokine receptor CCR2 on monocytes
Jana Grune et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Local effects of human PCSK9 on the atherosclerotic lesion
Ilaria Giunzioni et al.
JOURNAL OF PATHOLOGY (2016)
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis
Kazuyuki Yahagi et al.
NATURE REVIEWS CARDIOLOGY (2016)
PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement
Nicola Ferri et al.
ATHEROSCLEROSIS (2016)
MicroRNA-181b Improves Glucose Homeostasis and Insulin Sensitivity by Regulating Endothelial Function in White Adipose Tissue
Xinghui Sun et al.
CIRCULATION RESEARCH (2016)
Vein graft failure: from pathophysiology to clinical outcomes
Margreet R. de Vries et al.
NATURE REVIEWS CARDIOLOGY (2016)
Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial Remodeling
Marina Beltrami-Moreira et al.
PLOS ONE (2016)
Macrophage Notch Ligand Delta-Like 4 Promotes Vein Graft Lesion Development Implications for the Treatment of Vein Graft Failure
Jun-ichiro Koga et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Heparan sulfate proteoglycans fine-tune macrophage inflammation via IFN-β
Philip L. S. M. Gordts et al.
CYTOKINE (2015)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
Reducing Macrophage Proteoglycan Sulfation Increases Atherosclerosis and Obesity through Enhanced Type I Interferon Signaling
Philip L. S. M. Gordts et al.
CELL METABOLISM (2014)
Induction of Atherosclerosis in Mice and Hamsters Without Germline Genetic Engineering
Martin Maeng Bjorklund et al.
CIRCULATION RESEARCH (2014)
TPCA-1 Is a Direct Dual Inhibitor of STAT3 and NF-κB and Regresses Mutant EGFR-Associated Human Non-Small Cell Lung Cancers
Jing Nan et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Minimum curvilinearity to enhance topological prediction of protein interactions by network embedding
Carlo Vittorio Cannistraci et al.
BIOINFORMATICS (2013)
Syndecan-4 signaling at a glance
Arye Elfenbein et al.
JOURNAL OF CELL SCIENCE (2013)
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
F. Gerald R. Fowkes et al.
LANCET (2013)
Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
Peter Libby
NEW ENGLAND JOURNAL OF MEDICINE (2013)
From link-prediction in brain connectomes and protein interactomes to the local-community-paradigm in complex networks
Carlo Vittorio Cannistraci et al.
SCIENTIFIC REPORTS (2013)
Syndecan-4 Regulates Early Neutrophil Migration and Pulmonary Inflammation in Response to Lipopolysaccharide
Yoshinori Tanino et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels
Nicola Ferri et al.
ATHEROSCLEROSIS (2012)
Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice
Maxime Denis et al.
CIRCULATION (2012)
PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages
Zhihan Tang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Pathology of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Lesions
Saami K. Yazdani et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway
Chun-Yan Wu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers
I-Ming Wang et al.
MOLECULAR SYSTEMS BIOLOGY (2012)
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Evan A. Stein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rationale and practical techniques for mouse models of early vein graft adaptations
Peng Yu et al.
JOURNAL OF VASCULAR SURGERY (2010)
Genetic and Metabolic Determinants of Plasma PCSK9 Levels
Susan G. Lakoski et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
PCSK9: a convertase that coordinates LDL catabolism
Jay D. Horton et al.
JOURNAL OF LIPID RESEARCH (2009)
Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice
Thomas A. Lagace et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery
MS Conte et al.
JOURNAL OF VASCULAR SURGERY (2006)
Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques
JO Deguchi et al.
CIRCULATION (2005)
A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1)
M Hamon et al.
GLYCOBIOLOGY (2004)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
